McKee International Equity Portfolio
|
||||
Proposal
|
Proposed by
|
Mgt. Position
|
Registrant Voted
|
1)
|
To accept 2020 Business Report and Financial Statements.
|
Management
|
For
|
Voted - For
|
2)
|
Based on recent amendments to the "Template of Procedures for Election of Director" by the Taiwan Stock Exchange, to approve amendments to the ballot format
requirement for election of Directors set forth in TSMC's "Rules for Election of Directors".
|
Management
|
For
|
Voted - For
|
3)
|
To approve the issuance of employee restricted stock awards for year 2021.
|
Management
|
For
|
Voted - For
|
5.1
|
Director: Mark Liu*
|
Management
|
For
|
Voted - For
|
5.2
|
Director: C.C. Wei*
|
Management
|
For
|
Voted - For
|
5.3
|
Director: F.C. Tseng*
|
Management
|
For
|
Voted - For
|
5.4
|
Director: Ming-Hsin Kung*+
|
Management
|
For
|
Voted - For
|
5.5
|
Director: Sir Peter L. Bonfield#
|
Management
|
For
|
Voted - For
|
5.6
|
Director: Kok-Choo Chen#
|
Management
|
For
|
Voted - For
|
5.7
|
Director: Michael R. Splinter#
|
Management
|
For
|
Voted - For
|
5.8
|
Director: Moshe N. Gavrielov#
|
Management
|
For
|
Voted - For
|
5.9
|
Director: Yancey Hai#
|
Management
|
For
|
Voted - For
|
5.10
|
Director: L. Rafael Reif#
|
Management
|
For
|
Voted - For
|
1A.
|
Election of Director: Rosemary A. Crane
|
Management
|
For
|
Voted - For
|
1B.
|
Election of Director: Abbas Hussain
|
Management
|
For
|
Voted - For
|
1C.
|
Election of Director: Gerald M. Lieberman
|
Management
|
For
|
Voted - For
|
1D.
|
Election of Director: Prof. Ronit Satchi-Fainaro
|
Management
|
For
|
Voted - For
|
2.
|
To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.
|
Management
|
For
|
Voted - For
|
3.
|
To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until
Teva's 2022 annual meeting of shareholders.
|
Management
|
For
|
Voted - For
|